Growth Hormone Replacement and Quality of Life in Adults
Author Information
Author(s): Kołtowska-Häggström Maria, Kind Paul, Monson John P, Jonsson Björn
Primary Institution: KIMS Medical Outcomes, Pfizer Endocrine Care
Hypothesis
How does growth hormone replacement therapy affect the quality of life in adults with growth hormone deficiency?
Conclusion
The study confirmed a significant improvement in quality of life for patients undergoing growth hormone replacement therapy.
Supporting Evidence
- Patients showed a mean QoL-AGHDAutility gain of 0.32 after treatment.
- Women had a greater total observed QALY gain than men.
- QoL-AGHDAutility scores improved significantly during the first year of treatment.
Takeaway
This study shows that giving growth hormone to adults who don't have enough of it can make them feel much better over time.
Methodology
The study used a utility-weighted quality of life index to assess changes in quality of life in GH-deficient adults over 1 to 6 years.
Potential Biases
Potential selection bias due to the nature of the KIMS database, which includes only patients receiving GH treatment.
Limitations
The observational nature of the study may introduce selection bias and limit causal interpretations.
Participant Demographics
The cohort consisted of 894 participants (53% women) with a mean age of 45 years at entry into the study.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website